ABOUT  US

WHAT WE DO
ARTELLA Solutions specializes in Remote Patient Monitoring with a primary focus of Mobile Cardiac Telemetry (MCT) which involves a wireless cardiac patch to transmit electrocardiogram (ECG) information for real-time monitoring and ECG reporting. Physicians will receive 2 reports: a “24-hour” report and an “end of study” report when the prescribed period is completed.

ARTELLA also provides a unique Elite Customer Service model which provides a concierge service for patients receiving our service. The ARTELLA Customer Service Representative will assist patients and clinic staff by providing application of the MCT system at the clinic, the patient’s home or via video conferencing (telemedicine).
 
OUR HISTORY
The Company, founded by Leo Womack and Sepand Moshiri in September 2018, purchased a Mobile Cardiac Telemetry (MCT) reporting system. The Company then began marketing the MCT system with a wireless patch device, created a sales team, and promoted the industry’s first Elite Customer Service Model. The company was recognized and credentialed as an Independent Diagnostic Testing Facility (IDTF). On May 2020, the Company renamed itself Artella Solutions to create an innovative MCT electrocardiogram reporting system which was launched in September 2020. Today, the Artella strategy is to bring novel device innovations with its reporting platform system into the marketplace.

ARTELLA Executive Leadership

  • Larry W. Lawson

    Larry W. Lawson

    Chairman
  • Larry W. Lawson

    Following a brief successful career in music, Larry pivoted to healthcare, where he was first exposed to the medical device industry. From his early life to now, Lawson was a true visionary, gifted salesman and extraordinary organizer. He blended these unique set of talents when he joined Johnson and Johnson in 1970 as a sales representative. As he navigated through his career, he learned the intricacies of the industry and saw the need for top quality products in Latin America and the Middle East, eventually starting his first company, Mesco, Inc. in 1980 a medical products export company. After success with Mesco, Larry founded LifeMed, Inc. in 1983 to distribute German diagnostic instruments and devices. From there, he continued to establish other medical companies, eventually focusing on cardiology. Lawson founded eCardio in 2004 and after building it worldwide, he merged with Preventice a software company that attracted Merck as the primary shareholder followed by Boston Scientific. These significant opportunities allowed Lawson to form HeartcoR Solutions in 2015, an ECG Core Lab providing research and clinical trial management services to pharma, medical device, and biotech companies worldwide then Proxima Clinical Research in 2018, the only CRO exclusively located in the Texas Medical Center, the largest medical center in the world.

    Lawson is a 2018 recipient of the prestigious Horatio Alger Award, was named the 2009 Ernest & Young’s Health Science Entrepreneur of the Year, and is a recipient of the Houston Technology Center’s Lifetime Achievement Award for Life Sciences in 2017. Lawson served on the Board of GOOSE Capital (Grand Order Of Successful Entrepreneurs from 2014- 2019.

    Lawson is an active member of TMCx, is a team member of the Texas Medical Center Innovation Institute, serves on the TMC Venture Fund Board and serves on Boards for many medical device companies. Lawson is also a member of the Lamar University Spindletop Society, Legacy Society and President’s Circle, member of the CICE Advisory Council, and a former trustee of the Lamar University Foundation, Inc. Lawson also served as the 2018 LU Homecoming Parade Marshal, established the Larry W. Lawson Distinguished Faculty Fellowship in Engineering, has financially supported CICE, academics, and the College of Engineering. In addition, Lawson has assisted several LU students with introductions leading to internship opportunities. Lawson currently resides in Houston and is the founder and chairman of HeartcoR Solutions and Proxima Clinical Research.

  • Sepand Moshiri

    Sepand Moshiri

    President / CEO
  • Sepand Moshiri

    Sepand Moshiri -Sep- is a data driven executive and board member with over 20 years of consultative selling and strategic leadership, corporate turnaround, and client operations achievements in the medical devices, disruptive SaaS platform technology, value-based healthcare & services, Big Pharma, and capital markets industries. Sep also built the first and only Elite Customer Service (concierge) model in the Mobile Cardiac Telemetry (MCT) industry.

    Involved in various phases of start-ups, funding and acquisitions, Sep serves as a change agent within the cardiovascular innovations industry while executing tactical problem solving solutions. In 2010, he was instrumental in the creation of CardioNexus Corporation (Fairway Medical Technologies & Panasonic NA) to deploy an innovative diagnostic platform. From 2018-19, Sep served as the President of CorVitals of Texas Inc. (now, ARTELLA Solutions Inc.), the pioneering MCT monitoring and Digital Health organization which he co-founded. Currently, he is the Managing Director of Ramsey Financial Group (RFG), a single-family office which manages the Leo B. Womack Family Trust companies and largest shareholder of ARTELLA.

    Within management roles in both the Cardiology/Urology and US Government Relations divisions at Pfizer, Inc., Sep developed multi-faceted teams in preparation for launches of emerging first-in-class products throughout leading healthcare systems including VA Medical Centers and The Texas Medical Center. This propelled his significant long-term value at complex matrix medical device organizations. Through his consulting and sales executive roles, Sep led business turnaround in various healthcare entities, while enforcing sweeping departmental changes coupled with growing P&L responsibility.

    Sep was a founding shareholder and built the Client Operations vertical of the unique mobile 3D Mammography imaging network, Covia Health, whose mission was to define preventative healthcare in women within large-cap employers. At the Utilization Management company WNS-HealthHelp, he oversaw a $60M P&L and led a high performing group to manage 5.2M lives for its largest client, Humana, Inc., while negotiating large Medicare and Commercial Insurance contracts. This served as a precursor to founding and establishing ARTELLA as an Independent Diagnostic Testing Facility (IDTF) to achieve In-Network status with all Payors.

    Sep is a Houston Chapter Founder and Co-Chair, Sponsorship Committee of the Private Directors Association (PDA); Board Member at Fairway Medical Technologies; Board Member at ARTELLA; Board Director at Liprostin Group; Business Advisory Board at RedCrow (direct investment platform).

    Sep received a Bachelor of Science in Neurobiology with honors from Vanderbilt University and an MBA with highest honors from University of Houston C.T. Bauer College of Business.

  • Jacinta Fitzsimons

    Jacinta Fitzsimons

    EVP, Clinical Operations
  • Jacinta Fitzsimons

    Jacinta (Jess) Fitzsimons contributes 30 years of healthcare knowledge and expertise in the healthcare industry.  She achieved her general nursing degree in Ireland and a degree in Intensive and Cardiac care. She also received diplomas in Research methods and Microbiology in the Royal College of Surgeons, Dublin, Ireland. In 1995, Jess took on the role of CVICU Manager and STICU Charge Nurse and Educator at Memorial Hermann Hospital in Houston, Texas and later contributed to River Oaks Hospital as an Educator and Patient Safety Officer committed to caring for both patients and employees. She taught basic EKG rhythm classes identification and analysis at Lonestar College and within hospitals.

    In 2008, Jess helmed the Monitoring Center of Preventice Technologies as Director. She oversaw 260 employees working 24/7 in two centers, one in Houston and one in California, and was instrumental in establishing the California center as an Independent Diagnostic Testing Facility (IDTF). For both centers, she developed an EKG and customer service training program. Along with ensuring departmental and company performance goals were achieved, Jess was responsible for developing and maintaining the department’s budget. In addition to being accountable for the general administrative duties of scheduling, quality control in both the clinical and inventory setting, and ongoing staff education, Jess was involved with product development, assisting with the sales force, and building relationships with practices and physicians. As a leader, Jess is heralded for her team building practices, fostering positive discussions, and bringing out the best in her employees. Holding high standards for quality and accuracy attributed to her ability to run an efficient lab, effectively motivating and uniting her team around a vision, and striving toward excellence. Jess built rapport with the many constituents including clients, employers, and other professional organizations.

    She served as a Clinical Operations Consultant for HeartcoR Solutions, LLC in Chicago, Illinois before starting her own company, Infinity Heart Health LLC (IHH) in June 2018. As the Co-Founder and Clinical Director, she navigated her company to become a multifunctional remote healthcare business offering advanced solutions to enhance patient outcomes, providing instant data, and reducing workload and cost. She forged forward with new ideas as a vocal advocate for her remote EKG monitoring employees and made quality patient care her top priority. In addition, Jess assisted with the formation of Aura Health Solutions LLC, contributing to development of the Unica platform and mobile application as well as the training of the care team for Remote Patient Monitoring (RPM) and Critical Care Management (CCM).

    Over the last 8 years, she has contributed to the Advisory Boards for Brentwood College and Houston Community College. She is an active member of the Critical Rhythm Analysis Technician (CRAT) committee for Cardiovascular Credentialing International (CCI) for the past 10 years. As the current EVP of Clinical Operations for ARTELLA Solutions, Inc., Jess brings vast experience, passion, and innovations in all aspects of operating an IDTF, patient centric care, quality assurance, and results-driven action.

  • Joseph Hashim

    Joseph K. Hashim

    EVP, Commercialization and Corporate Strategy
  • Joseph K. Hashim

    Joseph K. Hashim is Executive Vice President of Commercialization and Corporate Strategy at Artella Solutions, Inc. Joseph brings over 20 years of executive leadership in developing healthcare sales organizations with extensive start-up experience. His expertise ranges from cardiovascular diagnostics, implantable devices, and cardiac ablation. Joseph has extensive work with CMS regulatory to open and credential Independent Diagnostic Testing Facilities and experience in FDA 510k market clearance submissions.

    In his consultancy, Joseph has been retained to create market strategy for digital health platforms such as Remote Patient Monitoring, Chronic Care Management, and Hospital-at-Home virtual care. Additionally, he worked with the Adventist Health System to structure and launch a population health betterment program. The Live Well Program was piloted and launched in multiple hospitals with local and state funding.

    Mr. Hashim comes to Artella from Abbott Laboratories, where he worked in Rhythm Management. Previously, he held executive level positions at Peerbridge Health and National Cardiac, where he successfully scaled operations and sales and ultimately sold the company. Prior, he held sales management rolls at nContact Inc. (acquired by Atricure) and Biotelemetry (acquired by Philips).

    Joseph holds B.A. degree from Pace University in Marketing and earned an M.B.A degree from Mercy College in operations leadership.

ARTELLA Board of Directors

  • Leo Womack

    Leo Womack

    Founder
  • Leo Womack

    Leo Womack began his career as a CPA with Arthur Anderson, leaving four years later to purchase and build a local CPA firm which he merged it into a national firm ten years after the purchase. During that same time period, Mr. Womack co-founded the 376-bed Park Plaza Hospital that was sold for a significant gain eight years later, which led him to a continued focus in real estate investing and development. Among numerous projects, his development group successfully redeveloped nine historical buildings in the San Antonio CBD, including the iconic Main Plaza Building.

    Throughout his career, Mr. Womack has sought to invest in exceptional people and companies, where he maintains a leadership role in financial planning and execution. Currently, this is accomplished through his position as CEO of Ramsey Financial Group (operating as a family office (http://www.ramseyfg.com) where he manages and controls the investment portfolio of his family trust. The firm and trust were established in 1992 and the investments within the trust are diversified into real estate and private and public companies.

    For over 30 years, Mr. Womack has been president of Gulf Equities Realty Corp. The firm manages a significant portfolio (www.gulfequities.com) of real estate assets in the greater Houston area.

    More recently Mr. Womack became the chairman of Petrolia Energy Corporation, (http://www.petroliaenergy.com) a small oil and gas company with a business strategy of acquiring proven, producing reserves, using technology to enhance reserve recovery.

    Mr. Womack is the founder of CorVitals of Texas, Inc. and serves as its Chairman of the Board.

  • Bernard Harris

    Dr. Bernard Harris, Jr.

    M.D., M.B.A., F.A.C.P.
  • Dr. Bernard Harris, Jr.

    Dr. Harris is currently Chief Executive Officer and Managing Partner of Vesalius Ventures, a venture capital firm, that invests in early to mid stage Healthcare technologies and companies. Prior to Vesalius Ventures, he was at NASA, a veteran astronaut for over eighteen years, he has logged more than 438 hours and traveled over 7.2 million miles in space. Currently, he is on the Board for the Houston Angel Network, Houston Technology Center and BioHouston. He is a member of the Board of Directors for Monebo Technologies, RMD Networks, U.S. Physical Therapy (Nasdaq: USPH), Sterling Bancshares (Nasdaq: SBIB), and the Space Agency. Dr. Harris is also the founder and president of the Harris Foundation, which supports math and science education and crime prevention programs for America’s youth. He is the recipient of numerous awards, including honorary doctorates from Stony Brook University (SUNY), Morehouse School of Medicine, and University of Hartford, NASA Space Flight Medal, NASA Award of Merit, a fellow of the American College of Physicians, and was the recipient of the 2000 Horatio Alger Award.

  • Larry W. Lawson

    Larry W. Lawson

    Chairman
  • Larry W. Lawson

    Following a brief successful career in music, Larry pivoted to healthcare, where he was first exposed to the medical device industry. From his early life to now, Lawson was a true visionary, gifted salesman and extraordinary organizer. He blended these unique set of talents when he joined Johnson and Johnson in 1970 as a sales representative. As he navigated through his career, he learned the intricacies of the industry and saw the need for top quality products in Latin America and the Middle East, eventually starting his first company, Mesco, Inc. in 1980 a medical products export company. After success with Mesco, Larry founded LifeMed, Inc. in 1983 to distribute German diagnostic instruments and devices. From there, he continued to establish other medical companies, eventually focusing on cardiology. Lawson founded eCardio in 2004 and after building it worldwide, he merged with Preventice a software company that attracted Merck as the primary shareholder followed by Boston Scientific. These significant opportunities allowed Lawson to form HeartcoR Solutions in 2015, an ECG Core Lab providing research and clinical trial management services to pharma, medical device, and biotech companies worldwide then Proxima Clinical Research in 2018, the only CRO exclusively located in the Texas Medical Center, the largest medical center in the world.

    Lawson is a 2018 recipient of the prestigious Horatio Alger Award, was named the 2009 Ernest & Young’s Health Science Entrepreneur of the Year, and is a recipient of the Houston Technology Center’s Lifetime Achievement Award for Life Sciences in 2017. Lawson served on the Board of GOOSE Capital (Grand Order Of Successful Entrepreneurs from 2014- 2019.

    Lawson is an active member of TMCx, is a team member of the Texas Medical Center Innovation Institute, serves on the TMC Venture Fund Board and serves on Boards for many medical device companies. Lawson is also a member of the Lamar University Spindletop Society, Legacy Society and President’s Circle, member of the CICE Advisory Council, and a former trustee of the Lamar University Foundation, Inc. Lawson also served as the 2018 LU Homecoming Parade Marshal, established the Larry W. Lawson Distinguished Faculty Fellowship in Engineering, has financially supported CICE, academics, and the College of Engineering. In addition, Lawson has assisted several LU students with introductions leading to internship opportunities. Lawson currently resides in Houston and is the founder and chairman of HeartcoR Solutions and Proxima Clinical Research.

  • Sepand Moshiri

    Sepand Moshiri

    Co-Founder
  • Sepand Moshiri

    Sepand Moshiri -Sep- is a data driven executive and board member with over 20 years of consultative selling and strategic leadership, corporate turnaround, and client operations achievements in the medical devices, disruptive SaaS platform technology, value-based healthcare & services, Big Pharma, and capital markets industries. Sep also built the first and only Elite Customer Service (concierge) model in the Mobile Cardiac Telemetry (MCT) industry.

    Involved in various phases of start-ups, funding and acquisitions, Sep serves as a change agent within the cardiovascular innovations industry while executing tactical problem solving solutions. In 2010, he was instrumental in the creation of CardioNexus Corporation (Fairway Medical Technologies & Panasonic NA) to deploy an innovative diagnostic platform. From 2018-19, Sep served as the President of CorVitals of Texas Inc. (now, ARTELLA Solutions Inc.), the pioneering MCT monitoring and Digital Health organization which he co-founded. Currently, he is the Managing Director of Ramsey Financial Group (RFG), a single-family office which manages the Leo B. Womack Family Trust companies and largest shareholder of ARTELLA.

    Within management roles in both the Cardiology/Urology and US Government Relations divisions at Pfizer, Inc., Sep developed multi-faceted teams in preparation for launches of emerging first-in-class products throughout leading healthcare systems including VA Medical Centers and The Texas Medical Center. This propelled his significant long-term value at complex matrix medical device organizations. Through his consulting and sales executive roles, Sep led business turnaround in various healthcare entities, while enforcing sweeping departmental changes coupled with growing P&L responsibility.

    Sep was a founding shareholder and built the Client Operations vertical of the unique mobile 3D Mammography imaging network, Covia Health, whose mission was to define preventative healthcare in women within large-cap employers. At the Utilization Management company WNS-HealthHelp, he oversaw a $60M P&L and led a high performing group to manage 5.2M lives for its largest client, Humana, Inc., while negotiating large Medicare and Commercial Insurance contracts. This served as a precursor to founding and establishing ARTELLA as an Independent Diagnostic Testing Facility (IDTF) to achieve In-Network status with all Payors.

    Sep is a Houston Chapter Founder and Co-Chair, Sponsorship Committee of the Private Directors Association (PDA); Board Member at Fairway Medical Technologies; Board Member at ARTELLA; Board Director at Liprostin Group; Business Advisory Board at RedCrow (direct investment platform).

    Sep received a Bachelor of Science in Neurobiology with honors from Vanderbilt University and an MBA with highest honors from University of Houston C.T. Bauer College of Business.

  • John Icardi

    John Icardi

  • John Icardi

    In 1983, John Icardi began cultivating his experience in healthcare services and medical device product commercialization as a surgical product sales representative in the Houston Texas Medical Center. Over 38 years, John has held and practiced roles from field sales to President & COO. He established and directed a successful medical device consultancy from 2000-2015, Strategic Business Works, Inc. (SBW). As President at SBW, John was a founding team member in 3 successfully divested medical device product/service start-ups (2 CROs); he has raised venture and hard money capital; built and operated direct and distributor sales forces, marketing teams, and led multiple annual strategic planning projects. He has a strong knowledge of global pharmaceutical and medical device regulatory requirements and ten years of direct involvement in global healthcare, regulatory affairs, including clinical research business development, and operations. John has successfully led in and out-license projects in addition to global product distribution partnerships. He has been a company board member and represented two physician specialty organizations, The Heart Rhythm Society and The American College of Preventive Medicine, with their industry partners. John created EGRESS Consultants in 2019 to aggregate top tier healthcare company turn-around and M&A talent and has been President & COO of HeartcoR Solutions LLC in Algonquin, IL since January 2021

    John holds undergraduate and graduate degrees from Florida State University and resides in Algonquin, IL.

  • Saad Alsaab

    Saad Alsaab, MD

  • Saad Alsaab, MD

    Content Coming Soon...